Comparative Molecular Docking Of Xanthine Oxidases: In Silico Study of Inhibition of Xanthine Oxidase by Synthetic (2nap1-2nap5) Series As Drug Compound In Parkinson’s Disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.